A study of 49 colonists from St. Mary's City, Maryland, reveals over 1.3 million living genetic relatives of founding settlers. The research team used DNA to propose possible identities for previously unknown individuals buried in the city's Chapel Field cemetery.
A new 23andMe study reveals genetic predictors for GLP-1 weight loss efficacy and side effects, providing a personalized approach to obesity treatment. The findings identify specific genetic variants associated with increased weight loss efficacy and nausea/vomiting side effects.
A 23andMe Research Institute study found that people with increased genetic risk for serious health conditions took positive actions after learning of their risk through direct-to-consumer genetic testing. Eighty-six percent received medical recommendations, and 88% adhered to them.
The update provides the most detailed look at African ancestry on the market, helping individuals with African heritage bypass historical 'brick walls'. With over 250 high-resolution genetic groups across Africa, members can now explore their West African ancestry and connect with specific groups in Nigeria, for example.
The Lung Cancer Genetics Study has launched an open-source data platform, offering no-cost access to de-identified data from consenting participants. Researchers can conduct analyses on germline genotyping, self-reported health and exposure data, and cancer-causing driver mutations, with longitudinal datasets to be added over time.